c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.
about
Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents.Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review.Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling.Integrated transcriptomic and proteomic analyses reveal ɑ-lipoic acid-regulated cell proliferation via Grb2-mediated signalling in hepatic cancer cells.Systemic treatments for hepatocellular carcinoma: challenges and future perspectives
P2860
c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
c-MET receptor tyrosine kinase ...... nced hepatocellular carcinoma.
@en
type
label
c-MET receptor tyrosine kinase ...... nced hepatocellular carcinoma.
@en
prefLabel
c-MET receptor tyrosine kinase ...... nced hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
c-MET receptor tyrosine kinase ...... nced hepatocellular carcinoma.
@en
P2093
Alessandro Granito
Elena Guidetti
Laura Gramantieri
P2860
P356
10.2147/JHC.S77038
P577
2015-04-24T00:00:00Z